Allspring Global Investments
UTHR icon

Allspring Global Investments’s United Therapeutics UTHR Stock Holding History

Allspring Global Investments’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.9M Sell
96,696
-49,828
-34% -$28.1M 0.08% 277
2026
Q1 		$83.6M Buy
146,524
+41,739
+40% +$20.8M 0.14% 176
2025
Q4 		$52M Buy
104,785
+14,976
+17% +$6.97M 0.08% 270
2025
Q3 		$39.4M Buy
89,809
+4,944
+6% +$1.66M 0.06% 357
2025
Q2 		$24.7M Buy
84,865
+2,101
+3% +$628K 0.04% 461
2025
Q1 		$25.4M Sell
82,764
-1,844
-2% -$632K 0.04% 459
2024
Q4 		$30.3M Sell
84,608
-96,697
-53% -$35.5M 0.05% 431
2024
Q3 		$65M Sell
181,305
-95,226
-34% -$32.2M 0.1% 250
2024
Q2 		$88.1M Buy
276,531
+91,597
+50% +$24.2M 0.14% 170
2024
Q1 		$42.5M Buy
184,934
+3,537
+2% +$798K 0.07% 376
2023
Q4 		$39.9M Sell
181,397
-18,571
-9% -$4.28M 0.07% 377
2023
Q3 		$45.2M Buy
199,968
+27,042
+16% +$6.23M 0.08% 324
2023
Q2 		$38.2M Sell
172,926
-21,763
-11% -$4.82M 0.06% 404
2023
Q1 		$43.6M Buy
194,689
+73,643
+61% +$18.2M 0.07% 370
2022
Q4 		$33.7M Sell
121,046
-104,816
-46% -$26.5M 0.06% 428
2022
Q3 		$47.3M Sell
225,862
-13,541
-6% -$3.03M 0.08% 317
2022
Q2 		$56.4M Sell
239,403
-81,056
-25% -$16.5M 0.09% 283
2022
Q1 		$57.5M Sell
320,459
-38,082
-11% -$7.25M 0.07% 335
2021
Q4 		$77.5M Buy
+358,541
New +$70.4M 0.09% 300

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Allspring Global Investments's UTHR Position: Q2 2026 in Review

Allspring Global Investments reduced its United Therapeutics (UTHR) stake by 34% in Q2 2026, selling an estimated $28.1M and leaving 96,696 shares worth $52.9M. The position accounts for 0.08% of the portfolio, ranked #277.

Allspring Global Investments first reported a position in UTHR in Q4 2021 and has held it in 19 quarters since. The position peaked at $88.1M in Q2 2024. 879 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Allspring Global Investments held 96,696 shares of United Therapeutics worth $52.9M as of Q2 2026.
  • Allspring Global Investments sold 49,828 United Therapeutics shares in Q2 2026, an estimated $28.1M.
  • United Therapeutics made up 0.08% of Allspring Global Investments's portfolio in Q2 2026, its #277 holding.
  • Allspring Global Investments first reported a position in United Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Allspring Global Investments's United Therapeutics position peaked at $88.1M in Q2 2024.
  • 879 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.